Status:

UNKNOWN

Effect of Intense Sport Practice in Athletes With Non-ischemic Scar

Lead Sponsor:

Rennes University Hospital

Conditions:

Athletes With Isolated Non-ischemic LGE With no Underlying "Labelled" Cardiomyopathy

Eligibility:

All Genders

15+ years

Brief Summary

The prognostic relevance of isolated non-ischemic LGE (i.e. with no underlying "labelled" cardiomyopathy) is unclear, and current guidelines to not state on the clearance of athlete with this type of ...

Detailed Description

The presence of a scar, assessed by late gadolinium enhancement (LGE) on cardiac resonance imaging (CMR), is associated with a poor prognosis in patients with ischemic heart disease or cardiomyopathy....

Eligibility Criteria

Inclusion

  • Any athlete, aged of more than 15 years, symptomatic or not,
  • in whom non-ischemic LGE with no underlying "labelled" cardiomyopathy is detected on CMR. Scare of an acute myocarditis will also be included.
  • Athletes will be defined by a practice of ≥4 hours/week of sport activity and/or competitive sport activity at the time of the assessment which triggered the realization of the 1st CMR.

Exclusion

  • Athletes with any unequivocal cardiac disease that might explain the LGE (i.e. hypertrophic cardiomyopathy, ischemic cardiac disease). In case of borderline or doubtful diagnosis the athlete can still be included (for example an athlete with a dilated LV and borderline function, or with borderline wall thickness).
  • Patients who refuse their participation in the study.
  • Patients under legal protection or deprived of their liberty.

Key Trial Info

Start Date :

October 5 2018

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

October 5 2025

Estimated Enrollment :

200 Patients enrolled

Trial Details

Trial ID

NCT03780231

Start Date

October 5 2018

End Date

October 5 2025

Last Update

December 19 2018

Active Locations (6)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 2 (6 locations)

1

Baker IDI Heart and Diabetes Institute

Melbourne, Australia

2

University Hospital Gasthuisberg

Leuven, Belgium

3

CHU de Rennes

Rennes, France, 35033

4

Saarland University

Saarbrücken, Germany